WELLBIOTEC CO.,LTD Logo

WELLBIOTEC CO.,LTD

A diversified company in biopharma, EV charging, logistics, and leather products.

010600 | KO

Overview

Corporate Details

ISIN(s):
KR7010600005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 영동대로106길 17 5층, 강남구

Description

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기검토의견부적정또는의견거절
Korean 6.5 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.3 MB
2025-06-05 00:00
횡령ㆍ배임사실확인
Korean 6.6 KB
2025-05-27 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 32.3 KB
2025-05-27 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 32.3 KB
2025-05-20 00:00
기타경영사항(자율공시) (상장폐지결정 효력정지 가처분 신청)
Korean 5.9 KB
2025-05-19 00:00
기타시장안내 (상장·공시위원회 결과)
Korean 4.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.3 MB
2025-04-23 00:00
기타시장안내 (개선계획 이행여부 심의요청서 접수)
Korean 10.4 KB
2025-04-14 00:00
기타시장안내 (개선기간 종료)
Korean 8.0 KB
2025-04-10 00:00
기타시장안내 (상장폐지 이의신청서 제출)
Korean 7.2 KB
2025-03-31 00:00
정기주주총회결과
Korean 18.9 KB
2025-03-28 00:00
사업보고서 (2024.12)
Korean 2.4 MB
2025-03-21 00:00
감사보고서제출
Korean 21.3 KB
2025-03-21 00:00
기타시장안내 (상장폐지 관련 안내)
Korean 9.2 KB

Automate Your Workflow. Get a real-time feed of all WELLBIOTEC CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WELLBIOTEC CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WELLBIOTEC CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.